Ładuje się......
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
The immunogenicity of protein therapeutics is an important safety and efficacy concern during drug development and regulation. Strategies to identify individuals and subpopulations at risk for an undesirable immune response represent an important unmet need. The major histocompatibility complex (MHC...
Zapisane w:
| Wydane w: | Blood Adv |
|---|---|
| Główni autorzy: | , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society of Hematology
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517663/ https://ncbi.nlm.nih.gov/pubmed/31053570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018030452 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|